We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+8.5%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+908.87%
AUM
$68.5B
AUM Growth
+$5.5B
(+8.7%)
Cap. Flow
+$1.71B
Cap. Flow
% of AUM
2.49%
Top 10 Holdings %
Top 10 Hldgs %
25.7%
Holding
1,699
New
105
Increased
875
Reduced
640
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$325M |
| 2 |
Dimensional International Small Cap ETF
DFIS
|
+$243M |
| 3 |
NVIDIA
NVDA
|
+$98.1M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$92.1M |
| 5 |
UnitedHealth
UNH
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$155M |
| 2 |
Zoetis
ZTS
|
+$65.2M |
| 3 |
Accenture
ACN
|
+$56.5M |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$46.9M |
| 5 |
Diageo
DEO
|
+$46.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.69% |
| 2 | Financials | 14.54% |
| 3 | Consumer Discretionary | 9.74% |
| 4 | Industrials | 9.25% |
| 5 | Healthcare | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Thermo Fisher Scientific
TMO
$220B
| $234M | 0.34% |
482,430
+75,993
| +19% | +$35.4M |
|
52
Coca-Cola
KO
$375B
| $233M | 0.34% |
3,518,019
+4,274
| +0.1% | +$294K |
|
53
Salesforce
CRM
$158B
| $233M | 0.34% |
981,178
+8,644
| +0.9% | +$2.18M |
|
54
Philip Morris
PM
$295B
| $230M | 0.34% |
1,420,056
-30,202
| -2% | -$5.08M |
|
55
American Express
AXP
$230B
| $227M | 0.33% |
683,515
+9,190
| +1% | +$2.92M |
|
56
Qualcomm
QCOM
$176B
| $227M | 0.33% |
1,364,408
+63,373
| +5% | +$10.1M |
|
57
Arista Networks
ANET
$238B
| $227M | 0.33% |
1,557,154
-11,610
| -0.7% | -$1.5M |
|
58
Chevron
CVX
$366B
| $225M | 0.33% |
1,445,704
+335,071
| +30% | +$51.9M |
|
59
O'Reilly Automotive
ORLY
$76.3B
| $224M | 0.33% |
2,079,284
-51,123
| -2% | -$5.14M |
|
60
Shopify
SHOP
$195B
| $220M | 0.32% |
1,479,047
+46,463
| +3% | +$6.3M |
|
61
iShares MSCI EAFE ETF
EFA
$80.2B
| $219M | 0.32% |
2,341,777
+952,877
| +69% | +$86.6M |
|
62
Chubb
CB
$135B
| $212M | 0.31% |
750,539
+26,893
| +4% | +$7.4M |
|
63
Intuitive Surgical
ISRG
$134B
| $211M | 0.31% |
472,350
-81,894
| -15% | -$39.3M |
|
64
Mitsubishi UFJ Financial
MUFG
$254B
| $211M | 0.31% |
13,240,940
+1,718,759
| +15% | +$25.4M |
|
65
Vertex Pharmaceuticals
VRTX
$126B
| $210M | 0.31% |
537,194
-3,336
| -0.6% | -$1.39M |
|
66
Advanced Micro Devices
AMD
$789B
| $208M | 0.3% |
1,285,093
+146,269
| +13% | +$23.6M |
|
67
TJX Companies
TJX
$178B
| $207M | 0.3% |
1,432,867
-20,818
| -1% | -$2.77M |
|
68
Barclays
BCS
$94.1B
| $204M | 0.3% |
9,886,650
+549,497
| +6% | +$10.9M |
|
69
CBRE Group
CBRE
$42.9B
| $203M | 0.3% |
1,288,799
+60,506
| +5% | +$9.36M |
|
70
Applied Materials
AMAT
$428B
| $196M | 0.29% |
957,386
+18,279
| +2% | +$3.32M |
|
71
Merck
MRK
$318B
| $194M | 0.28% |
2,310,247
+371,039
| +19% | +$30.6M |
|
|
SPYM
72
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| $194M | 0.28% |
2,475,110
-621,639
| -20% | -$46.9M |
|
73
ASML
ASML
$669B
| $192M | 0.28% |
198,248
-1,227
| -0.6% | -$965K |
|
|
SCHW
74
Charles Schwab
SCHW
$187B
| $190M | 0.28% |
1,994,892
-11,441
| -0.6% | -$1.09M |
|
75
Citigroup
C
$226B
| $190M | 0.28% |
1,875,843
+19,623
| +1% | +$1.86M |
|
Similar funds
BC
CBU
Natixis Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Natixis Advisors held 1,699 positions worth $68.5B, up 8.7% from $63B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Natixis Advisors's Q3 2025 filing shows 105 new, 875 increased, 640 reduced and 77 closed positions. Its largest new stake was Amrize Ltd: 788,840 shares worth $38.3M. The largest sale was Vanguard Russell 2000 ETF, an estimated $155M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
- Natixis Advisors's largest Q3 2025 buy was Amrize Ltd: 788,840 shares worth $38.3M.
- Natixis Advisors added most to Apple in Q3 2025, an estimated $325M increase.
- Natixis Advisors's biggest Q3 2025 reduction was Vanguard Russell 2000 ETF, cutting an estimated $155M.
- Natixis Advisors fully exited Hess in Q3 2025, selling an estimated $41.1M.
- Natixis Advisors's ten largest holdings make up 26% of its $68.5B portfolio in Q3 2025.
- Natixis Advisors opened 105 new positions and closed 77 in Q3 2025.
- Natixis Advisors's portfolio value rose 8.7% quarter-over-quarter to $68.5B.
Based on Natixis Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.